This paper studied the dynamics of local immunity factors of the oral cavity in women with recurrent aphthous stomatitis against the background of urogenital infection. The research proves the maximum efficacy of hydroxyzine hydrochloride, aminodihydrophthalasindione sodium and Eplan used in multiple treatments of recurrent aphthous stomatitis in patients with urogenital infection as evidenced by a marked reduction in the coefficient of local immunity factors balance, which is observed as early as on day 7 of the therapy provided. Moreover, the findings show the growth of immunological parameters of oral fluid (lysozyme and SIgA), the normalization of the coefficient of local immunity factors balance in the treatment of recurrent aphthous stomatitis in women with urogenital infection, the improvement being observed 3 months after the treatment suggesting a favorable local immunity of the oral cavity.
. The disease is long lasting and characterized by frequent recurrences, resistance to the treatment provided [1] [4] [6] . Some scientists distinguish a variety of etiological factors, among them there are immune, neurogenic, infection-allergic and other theories of RAS origin [1] [2] [5] . Reports in literature give a variety of different techniques and medications for RAS treatment. However, RAS cure is still an urgent problem [1] [2] [3] [4] [5] [7] .
In this regard, our study aimed at optimizing the methods used to treat chronic recurrent aphthous stomatitis (CRAS). To accomplish the purpose, we set a problem of proving the use of some medications in RAS therapy based on the study of the changes; a number of immunological parameters of oral fluid undergo during the treatment.
Materials and Methods
The present study was carried out at the Department of Therapeutic Dentistry, Nizhny Novgorod State Medical Academy for 12 years. The study included data from a survey of 1000 women aged 25 -35 years with chronic recurrent aphthous stomatitis, 500 practically healthy women were included in the control group.
Among them, groups of patients with chronic recurrent aphthous stomatitis (CRAS) were identified who applied to the dental clinic NizhGMA, MLPU "Women's Consultation No. 5" in Nizhny Novgorod, the NOCC, the Research Institute of Preventive Medicine NizhGMA, OC AIDS with complaints of pain in the SDR and from the urogenital tract reproductive problems, as well as for preventive examination. We performed a clinical examination of 300 women with RAS associated with urogenital infection, aged from 25 to 35 years (mean age 28.2 ± 1.4) followed by a treatment. Exclusion criteria were severe somatic diseases (diabetes, HIV, cancer, blood diseases, etc.), refusal of examination and treatment, age to 25 and after 35 years. Eligibility criteria are women from 25 to 35 years old with gynecological diseases and СRAS.
CRAS patients were randomized in tree groups, 100 women in each group, depending on the treatment techniques used: group I (main group) with drug therapy including general treatment combined with therapeutic agents: hydroxyzine hydrochloride, aminodihydrophthalasindione sodium, and local treatment: Eplan applied on problem oral mucosa areas; group II with drug therapy consisting in general treatment combined with therapeutic agents: hydroxyzine hydrochloride, aminodihydrophthalasindione sodium, and local treatment-problem areas of oral mucosa were covered by solcoseryl (dental adhesive paste); and group III with drug therapy including general treatment with antihistamines and multivitamin preparations administered, and local treatment: solcoseryl (dental adhesive paste) applied on problem oral mucosa areas.
Patients of all 3 groups (100 in each) with CRAS for anamnestic data, complaints for primary treatment, age, baseline values of dental and gynecological status were comparable. Patients of the examined groups were examined hor- The study included several items:
1) Dental examination of women, diagnosis of CRAS, the study of the occurrence of dental diseases in women with gynecological pathology evaluation of dental status in women with gynecological pathology.
2) General clinical methods of examination. IgG, IgA is concentration of immunoglobulins; la is lysozyme activity in secretion;
40% is conditional norm of lysozyme activity; 0.6 is IgG/IgA relationship, which was true in most healthy people.
For the present study we used oral fluid samples, 3 -5 ml, taken in the morning, fasting, with no stimulation, and kept in a fridge at −20˚C till the laboratory stage.
The findings were statistically processed using the methods for findings reliability assessment, analysis of variance, and autocorrelation according to standard techniques. The obtained data were processed and analyzed using Microsoft Office (Excel) application programs, and a software statistical package "Stadia" and "Statistiсa 7.0". Table 1 shows the findings of immunological parameters of oral fluid in the treatment of 300 patients with RAS and urogenital infection, and 50 apparently healthy subjects (control).
Results
The represented data show a slight IgA decrease in the examined women compared to controls, on day 7 after the treatment there was a significant decrease of IgA level (p ≤ 0.05), with the following increase by month 3.
IgG amount was lower in the examined women compared to those of the control group, and decreased sharply by month 3 (p ≤ 0.05).
Lysozyme level was significantly reduced in RAS patients compared to the controls (p ≤ 0.05). Significant lysozyme decrease was found by day 7 after therapy (p ≤ 0.05), while on day 90 its level was significantly higher than the initial one.
In patients with RAS and urogenital infection C b was significantly higher Thus, RAS therapy resulted in C b decrease in all 3 groups, the maximum effect was found in group I as early as on day 7 after the treatment initiation.
Discussion
There are a lot of reviews on RAS [4] [17] . In studies laser therapy is one of the suggested treatments to reduce patients' discomfort [10] [15] [18] . In another study the application of ozone on RAS lesions was used for treatment [19] .
In the literature available to us and to the best of our knowledge, this study is the first of such type, which demonstrates the local immunity of the oral cavity in women with RAS associated with urogenital infection.
In the present examination a significant increase in the immunological indices of the oral fluid (IgG, SIgA, Xb.) was observed in the treatment of patients with aphthous stomatitis and urogenital infection with the scheme proposed by us, using atarax, eplan and galavit, most pronounced at 3 months of treatment.
These changes may be associated with the effect of the drug's use. So, the mechanism of Galavit action is associated with its ability to regulate the functional and metabolic activity of innate and adaptive immunity (monocytes, macrophages, neutrophils, natural killers, and others). Galavit normalizes the phagocytic activity of monocytes/macrophages, the neutrophils bactericidal activity and the cytotoxic activity of NK cells. At the same time, restoring the reduced activity of immune cells, the drug increases the body's resistance to infectious diseases of bacterial, viral and fungal etiology, contributes to a more rapid elimination of the pathogen from the body, and reduces the frequency, severity and duration of infections. In addition, Galavit® normalizes antibody production, increases the functional antibodies activity (affinity), indirectly regulates the production of endogenous interferons (IFN-α, IFN-γ) by producing cells. In inflammatory diseases, the drug reversibly (for 6 -8 hours) inhibits the excessive synthesis of hyperactive macrophages of tumor necrosis factor-α, interleukin-1, interleukin-6 and other proinflammatory cytokines, the level of which determines the degree of inflammatory reactions, their cyclicity, as well as the severity of intoxication of the organism. Galavit® reduces the production of reactive oxygen species by hyperactive macrophages, thereby reducing the level of oxidative stress and protecting tissues and organs from the damaging effects of radicals. Normalization of excessively increased functional activity of phagocytic cells leads to the restoration of their antigen presenting and regulating function, reducing the level of auto-aggression.
Atarax (a derivative of diphenylmethane), has a moderate anxiolytic activity; also has a sedative, antiemetic, antihistamine and m-anticholinergic action. It blocks central m-cholinergic and histamine H1 receptors and inhibits the certain subcortical zones activity.
Eplan has a bactericidal, anti-inflammatory, wound-healing, regenerating and analgesic effect, which is provided by the active ingredients of the drug.
Thus, the combined use of these drugs has an impact on different pathogenesis of recurrent aphthous stomatitis (RAS), leading, inter alia, to an increase in the immunological resistance.
Conclusion
The study carried out proves maximum efficiency of hydroxyzine hydrochloride, aminodihydrophthalasindione sodium, and Eplan (group I) used in the combination therapy of RAS in women with urogenital infection as evidenced by significant C b decrease in group I as early as on day 7 of therapy. Moreover, the findings suggest the increase of immunological parameters of the oral fluid (lysozyme and SIgA), the normalization of C b values during the treatment of recurrent aphthous stomatitis in women with urogenital infection, the normalization being the most significant on month 3 after therapy, indicating a favourable local immunity of the oral cavity.
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